{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:46:22Z","timestamp":1784814382482,"version":"3.55.0"},"reference-count":41,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Genomic testing for prostate cancer (PCa) clinical management and hereditary cancer assessment has grown in clinical impact; however, challenges remain regarding optimal implementation and end-user confidence. The Decision-making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) survey was designed to collect information regarding utility and understanding of genomic testing from PCa health care providers, researchers, and stakeholders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>The DECIDE survey was administered online from October 2022 to January 2023 with 18 multiple-response questions. Survey domains included self-confidence with ordering and interpreting germline and somatic genomic tests, process of testing and use of results, decision-making factors, and barriers to testing. Data were summarized by evaluating counts and percentages of responses, and the results were presented by descriptive statistics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>One hundred twenty-two participants completed the survey. The majority were medical oncologists (70%) and at academic medical centers (89%). Self-confidence was high in knowing indications for genomic testing (82% respondents) but lower in interpretation of results, especially from circulating tumor DNA (52%). Confidence varied in interpreting pathogenic variants (65% high confidence), variants of unknown significance (47%), and incidental findings from genomic tests (35%). Common barriers to testing were difficulty obtaining tissue (71%) and cost (35%). Testing utility was sometimes limited by inability to obtain the recommended treatment (33%). Most of the respondents (55%) agreed that lack of education and training of health care professionals regarding genomic testing is impeding clinical translation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>The DECIDE survey provided critical insights into challenges with genomic testing, from provider confidence in interpretating results to testing and practice barriers. The results inform next steps to further educate PCa providers and to collectively improve testing and result reporting for enhanced implementation of PCa genomic testing.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/po-24-00821","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:59:14Z","timestamp":1747339154000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey"],"prefix":"10.1200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5253-0551","authenticated-orcid":true,"given":"Rhonda L.","family":"Bitting","sequence":"first","affiliation":[{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Duke University School of Medicine, Durham, NC"},{"name":"Durham VA Healthcare System, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3204-8482","authenticated-orcid":true,"given":"Christopher","family":"McNair","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2399-0329","authenticated-orcid":true,"given":"Alexander W.","family":"Wyatt","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada"},{"name":"Michael Smith Genome Sciences Centre and Clinical Cancer Genomics Program, BC Cancer, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5606-0908","authenticated-orcid":true,"given":"Gillian","family":"Vandekerkhove","sequence":"additional","affiliation":[{"name":"Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7750-9276","authenticated-orcid":true,"given":"Taehwa","family":"Choi","sequence":"additional","affiliation":[{"name":"School of Mathematics, Statistics and Data Science, Sungshin Women's University, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3631","authenticated-orcid":true,"given":"Amy E.","family":"Leader","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Blanding-Godbolt","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gross","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, Yale Cancer Center, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8019-1526","authenticated-orcid":true,"given":"Khaldoun","family":"Hamade","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-2777","authenticated-orcid":true,"given":"Susan","family":"Halabi","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Duke University, Durham, NC"},{"name":"Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-5913","authenticated-orcid":true,"given":"Veda N.","family":"Giri","sequence":"additional","affiliation":[{"name":"Yale University School of Medicine, Yale Cancer Center, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_6_2_2","volume-title":"Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 3.2024","author":"National Comprehensive Cancer Network","unstructured":"National Comprehensive Cancer Network: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic. Version 3.2024. https:\/\/www.nccn.org"},{"key":"e_1_3_6_3_2","volume-title":"Prostate Cancer. Version 4.2024","author":"National Comprehensive Cancer Network","unstructured":"National Comprehensive Cancer Network: Prostate Cancer. Version 4.2024. https:\/\/www.nccn.org"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02608"},{"key":"e_1_3_6_5_2","article-title":"Toward informed selection and interpretation of clinical genomic tests in prostate cancer","author":"Vandekerkhove G","unstructured":"Vandekerkhove G, Giri VN, Halabi S, et al: Toward informed selection and interpretation of clinical genomic tests in prostate cancer. JCO Precis Oncol 10.1200\/PO.23.00654","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506859"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30684-9"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706450"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903387"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1810858"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200043"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.06.009"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01055-3"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30445-9"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714448"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02005"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.6086"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2021-0153"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2020.100212"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24172"},{"key":"e_1_3_6_22_2","volume-title":"PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry","author":"PRECISION Registry","unstructured":"PRECISION Registry: PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry. https:\/\/www.precision-registry.com\/"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2015.0061"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atg.2016.05.004"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.5161"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00692-y"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI132031"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0931"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.06.001"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0007"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168277"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0050"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00046"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603144"},{"key":"e_1_3_6_35_2","article-title":"Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making","author":"Abida W","unstructured":"Abida W, Armenia J, Gopalan A, et al: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making. JCO Precis Oncol 10.1200\/PO.17.00029","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_36_2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4986365"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.04.013"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2024.07.113"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2022.11.011"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.04.002"},{"key":"e_1_3_6_41_2","article-title":"Homologous recombination repair gene variants and outcomes among patients with prostate cancer treated with poly (ADP-ribose) polymerase inhibitors","author":"Price MJ","unstructured":"Price MJ, Vashistha V, Winski D, et al: Homologous recombination repair gene variants and outcomes among patients with prostate cancer treated with poly (ADP-ribose) polymerase inhibitors. JCO Precis Oncol 10.1200\/PO.21.00461","journal-title":"JCO Precis Oncol"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06737-1"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-24-00821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T19:59:33Z","timestamp":1747943973000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-24-00821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":41,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1200\/PO-24-00821"],"URL":"https:\/\/doi.org\/10.1200\/po-24-00821","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2400821"}}